Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Rheumatic Diseases D012216 7 associated lipids
Rhinitis D012220 10 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Osteosarcoma D012516 50 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Seizures D012640 87 associated lipids
Shock D012769 11 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Shock, Septic D012772 11 associated lipids
Shock, Traumatic D012774 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Sirois MG and Edelman ER VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. 1997 Am. J. Physiol. pmid:9227554
Hines KL and Fisher RA Regulation of hepatic glycogenolysis and vasoconstriction during antigen-induced anaphylaxis. 1992 Am. J. Physiol. pmid:1375439
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Rioux KP and Wallace JL Mast cell activation augments gastric mucosal injury through a leukotriene-dependent mechanism. 1994 Am. J. Physiol. pmid:8203531
Haller H et al. Endothelin increases [Ca2+]i, protein phosphorylation, and O2-. production in human alveolar macrophages. 1991 Am. J. Physiol. pmid:1662920
Suematsu M et al. In vivo visualization of oxidative changes in microvessels during neutrophil activation. 1993 Am. J. Physiol. pmid:8096123
Huber W et al. Leukotriene B4 and C4 production in isolated rat gastric mucosal cells. 1993 Am. J. Physiol. pmid:8279553
Del Maschio A et al. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. 1990 Am. J. Physiol. pmid:2156456
Kubes P et al. Platelet-activating factor-induced mucosal dysfunction: role of oxidants and granulocytes. 1991 Am. J. Physiol. pmid:1647676
Sasaki T et al. Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland. 1989 Am. J. Physiol. pmid:2692465
Brock TA and Gimbrone MA Platelet activating factors alters calcium homeostasis in cultured vascular endothelial cells. 1986 Am. J. Physiol. pmid:3717361
Kubes P et al. Leukocyte-induced vascular protein leakage in cat mesentery. 1991 Am. J. Physiol. pmid:1684268
Kurose I et al. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. 1996 Am. J. Physiol. pmid:8779980
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Sun XM et al. Role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. 1996 Am. J. Physiol. pmid:8772517
Suzuki M et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. 1998 Am. J. Physiol. pmid:9458712
Neuwirth R et al. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells. 1989 Am. J. Physiol. pmid:2705543
Kinnula VL et al. Release of reactive oxygen species by guinea pig tracheal epithelial cells in vitro. 1992 Am. J. Physiol. pmid:1616055
Harris NR et al. Capillary filtration during acute inflammation: role of adherent neutrophils. 1993 Am. J. Physiol. pmid:7902014
Gallin EK Evidence for a Ca-activated inwardly rectifying K channel in human macrophages. 1989 Am. J. Physiol. pmid:2750892
Ferrer-Lopez P et al. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. 1990 Am. J. Physiol. pmid:2360620
Wallace JL et al. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. 1989 Am. J. Physiol. pmid:2650567
Handa RK et al. Platelet-activating factor is a renal vasodilator in the anesthetized rat. 1990 Am. J. Physiol. pmid:2360650
Perico N et al. Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats. 1991 Am. J. Physiol. pmid:1713421
Wang J and Dunn MJ Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. 1987 Am. J. Physiol. pmid:2827506
Lang CH et al. Platelet-activating factor-induced increases in glucose kinetics. 1988 Am. J. Physiol. pmid:3348371
Kornecki E and Ehrlich YH Diminished responsiveness of human platelets to platelet-activating factor during pregnancy. 1990 Am. J. Physiol. pmid:2396687
Sun X et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. 1997 Am. J. Physiol. pmid:9252509
Saito M et al. Association of granular exocytosis with Ca(2+)-activated K+ channels in human eosinophils. 1997 Am. J. Physiol. pmid:9252535
Dobrowsky RT et al. Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia. 1991 Am. J. Physiol. pmid:2035668
Chang SW et al. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. 1989 Am. J. Physiol. pmid:2801951
Mózes T et al. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. 1989 Am. J. Physiol. pmid:2802004
Kobayashi I et al. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. 1994 Am. J. Physiol. pmid:8160825
Hines KL et al. PAF increases hepatic vascular resistance and glycogenolysis in vivo. 1991 Am. J. Physiol. pmid:1848410
Schlondorff D et al. Relationship of GTP-binding proteins, phospholipase C, and PGE2 synthesis in rat glomerular mesangial cells. 1989 Am. J. Physiol. pmid:2492160
Kubes P et al. Platelet-activating factor-induced microvascular dysfunction: role of adherent leukocytes. 1990 Am. J. Physiol. pmid:2301577
Bellan JA et al. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat. 1992 Am. J. Physiol. pmid:1379004
Chang SW et al. Beneficial effect of a platelet-activating factor antagonist, WEB 2086, on endotoxin-induced lung injury. 1990 Am. J. Physiol. pmid:2301603
Pique JM et al. Influence of morphine or capsaicin pretreatment on rat gastric microcirculatory response to PAF. 1990 Am. J. Physiol. pmid:2316650
Arnould T et al. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. 1993 Am. J. Physiol. pmid:8098907
Koyama S et al. Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. 1995 Am. J. Physiol. pmid:7631812
Miura S et al. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. 1993 Am. J. Physiol. pmid:8498509
Martins MA et al. Release of tachykinins by histamine, methacholine, PAF, LTD4, and substance P from guinea pig lungs. 1991 Am. J. Physiol. pmid:1722649
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Duque I et al. Effects of reactive oxygen species on cultured rat mesangial cells and isolated rat glomeruli. 1992 Am. J. Physiol. pmid:1415575
Johnson A et al. Tumor necrosis factor-alpha primes pulmonary hemodynamic response to N-formyl-L-methionyl-L-leucyl-L-phenylalanine. 1991 Am. J. Physiol. pmid:1656789
Kruse-Elliott KT et al. Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function. 1992 Am. J. Physiol. pmid:1415600
Milhoan KA et al. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. 1992 Am. J. Physiol. pmid:1415623
Dorn GW and Davis MG Differential megakaryocytic desensitization to platelet agonists. 1992 Am. J. Physiol. pmid:1415671
Faden AI and Tzendzalian PA Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. 1992 Am. J. Physiol. pmid:1415805